Amphastar Pharmaceuticals (AMPH) Long-Term Investments (2020 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Long-Term Investments of $14.4 million for Q1 2026, up 143.53% year-over-year from $5.9 million in Q1 2025, and down 0.69% quarter-over-quarter from $14.5 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Long-Term Investments (2020 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Long-Term Investments history runs 7 years deep, the most recent figure standing at $14.4 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 143.53% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $14.4 million (up 143.53% YoY), while the FY2025 annual figure was $14.5 million, up 31.87% from the prior year.
- Long-Term Investments for Q1 2026 stood at $14.4 million, down from $14.5 million in the prior quarter.
- The five-year high for Long-Term Investments was $14.7 million in Q4 2023, with the low at $972000.0 in Q3 2023.
- The 5-year median for Long-Term Investments is $5.9 million (2025), against an average of $7.5 million.
- The sharpest annual moves came in 2024 and 2025: Long-Term Investments soared 867.08% in 2024, then tumbled 79.41% in 2025.
- Amphastar Pharmaceuticals' Long-Term Investments stood at $4.5 million in 2022, then soared by 226.33% to $14.7 million in 2023, then fell by 25.12% to $11.0 million in 2024, then jumped by 31.87% to $14.5 million in 2025, then dropped by 0.69% to $14.4 million in 2026.
- Business Quant data shows AMPH's Long-Term Investments at $14.4 million in Q1 2026, $14.5 million in Q4 2025, and $13.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 60.00 Mn |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 16.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.30 Mn |
| Mar 31, 2026 | 14.40 Mn |
| Dec 31, 2025 | 14.50 Mn |
| Sep 30, 2025 | 13.30 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 5.91 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Sep 30, 2024 | 9.40 Mn |
| Jun 30, 2024 | 9.94 Mn |
| Mar 31, 2024 | 7.80 Mn |
| Dec 31, 2023 | 14.69 Mn |
| Sep 30, 2023 | 972,000.00 |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 4.50 Mn |
| Sep 30, 2022 | 2.69 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Dec 31, 2021 | 3.40 Mn |
| Sep 30, 2021 | 4.19 Mn |